In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-05-24
DOI
10.3389/fcimb.2017.00209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship of various infection control interventions to the prevalence of multidrug-resistant Pseudomonas aeruginosa among U.S. hospitals
- (2016) Victor R. Buford et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance
- (2016) Soon-Ee Cheah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon
- (2016) Ahmad Al Atrouni et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data
- (2016) Kamal Chamoun et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii
- (2015) Tze Peng Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin, mechanisms and prevalence of resistance
- (2015) Abed Zahedi Bialvaei et al. CURRENT MEDICAL RESEARCH AND OPINION
- In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis
- (2015) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon
- (2015) D. Hammoudi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam
- (2015) Vien Le Minh et al. JOURNAL OF MEDICAL MICROBIOLOGY
- High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
- (2015) Ali S Omrani et al. Annals of Clinical Microbiology and Antimicrobials
- Determination of In Vitro Activities of Polymyxin B and Rifampin in Combination with Ampicillin/Sulbactam or Cefoperazone/Sulbactam against Multidrug-Resistant Acinetobacter baumannii by the E-test and Checkerboard Methods
- (2015) Emel Sesli Cetin et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- OXA -Lactamases
- (2014) B. A. Evans et al. CLINICAL MICROBIOLOGY REVIEWS
- Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
- (2014) A. Batirel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war
- (2014) Rayane Rafei et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
- (2014) C. D. Doern JOURNAL OF CLINICAL MICROBIOLOGY
- Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates
- (2014) Abdollah Ardebili et al. Jundishapur Journal of Microbiology
- Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Hee Ji Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline: an update
- (2013) Gary E. Stein et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
- (2012) Nabil Karah et al. DRUG RESISTANCE UPDATES
- Acinetobacter baumannii
- (2012) Aoife Howard et al. Virulence
- The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: An update on the regional and local epidemiology
- (2012) Rima I. El-Herte et al. Journal of Infection and Public Health
- In VitroAntibiotic Synergy in Extensively Drug-ResistantAcinetobacter baumannii: the Effect of Testing by Time-Kill, Checkerboard, and Etest Methods
- (2010) Thean Yen Tan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Confronting multidrug-resistant Acinetobacter baumannii: a review
- (2010) Ioannis K. Neonakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae
- (2010) Caroline Dallenne et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii
- (2009) C. Moubareck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter: an old friend, but a new enemy
- (2009) K.J. Towner JOURNAL OF HOSPITAL INFECTION
- A Plasmid-Borne blaOXA-58 Gene Confers Imipenem Resistance to Acinetobacter baumannii Isolates from a Lebanese Hospital
- (2008) R. Zarrilli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More